Imperial College London

DrKatrinaPollock

Faculty of MedicineDepartment of Infectious Disease

Honorary Clinical Senior Lecturer
 
 
 
//

Contact

 

k.pollock

 
 
//

Location

 

455Norfolk PlaceSt Mary's Campus

//

Summary

 

Summary

I am Senior Clinical Research Fellow in vaccinology and Honorary Consultant in genitourinary medicine at Imperial College London and Imperial College Healthcare NHS Trust. I read medicine at Newnham College, University of Cambridge, and Imperial College London before completing speciality training as a clinician scientist in genitourinary medicine and immunology. My research investigates diversity in T cell responses to accelerate discovery in vaccine design and implementation. I lead first-in-human trials and experimental medicine studies of novel vaccines against hard-to-target pathogens including HIV and chlamydia. I am Chief and Principal Investigator for the Imperial College London self amplifying RNA SARS-CoV-2 vaccine and Oxford Astra-Zeneca COVID-19 vaccine trials. I received a Department of Infectious Disease award for substantial and exceptional achievement during the COVID-19 pandemic. 

 

 

Publications

Journals

Thwaites R, Uruchurtu ASS, Negri VA, et al., 2023, Early mucosal events drive distinct mucosal and systemic antibody responses to live attenuated influenza vaccine, Nature Communications, Vol:14, ISSN:2041-1723

Liu Z, Alexander J, Eng K, et al., 2023, Antibody responses to Influenza vaccination are diminished in patients with inflammatory bowel disease on infliximab or tofacitinib, Journal of Crohn's and Colitis, ISSN:1873-9946

Liu Z, Alexander J, Le K, et al., 2023, Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study, Eclinicalmedicine, Vol:64, ISSN:2589-5370

Khan M, Bradshaw D, Brown CS, et al., 2023, Characterization of rare spontaneous human immunodeficiency virus viral controllers attending a national United Kingdom clinical service using a combination of serology and molecular diagnostic assays, Open Forum Infectious Diseases, Vol:10, ISSN:2328-8957

Writing Committee for the REMAP-CAP Investigators, Lawler PR, Derde LPG, et al., 2023, Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support–free days in patients hospitalized with COVID-19, Jama: Journal of the American Medical Association, Vol:329, ISSN:0098-7484, Pages:1183-1196

More Publications